Royal Stoke University Hospital is a teaching and research hospital at Hartshill in the English county of Staffordshire. It lies in the city of Stoke-on-Trent, near the border with Newcastle-under-Lyme, and is one of the largest hospitals in the country and a major local employer, with over 6,000 staff.

There are 1,328 beds in Royal Stoke University Hospital.

During the past decade, Royal Stoke University Hospital conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 17 clinical trials were completed, i.e. on average, 30.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 15 clinical trials were completed. i.e. 107.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Stoke University Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "University College, London" with 4 trials sponsored and "University of Leeds" with 4 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Stoke University Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "British Heart Foundation" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 101 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "Royal Stoke University Hospital" are "Multiple Myeloma" (6 trials), "Atrial Fibrillation" (3 trials), "Breast Cancer" (3 trials), "Lung Diseases, Interstitial" (3 trials) and "Cervical Cancer" (2 trials). Many other conditions were trialed in "Royal Stoke University Hospital" in a lesser frequency.

Most popular intervention types in "Royal Stoke University Hospital" are "Drug" (50 trials), "Other" (6 trials), "Procedure" (6 trials), "Radiation" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials), "Dexamethasone" (3 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Stoke University Hospital" are 58 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Stoke University Hospital". undefined are not yet recruiting, 18 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Royal Stoke University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Stoke University Hospital, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".